The Problem
  • Current Options Inadequately Address Pain and Are Associated with Significant Side Effects​
  • Severe pain from acute injury and chronic wounds requires new treatment solutions
  • Presently, treatment of wound pain at the time of trauma is particularly challenging
  • NSAIDs frequently do not alleviate pain
  • Opioid analgesics, even if available, are highly associated with side effects and threaten addiction and dependence
  • Failure to treat acute pain increases the risk of developing chronic pain and Post-Traumatic-Stress-Disorder

The
Vapogenix
​Solution
A locally acting novel formulation of volatile general anesthetics which are administered topically at or near the site of peripheral pain.  Results from a Phase 2 Clinical Study of VPX638 demonstrated rapid and prolonged pain relief resulting in a reduction or elimination of chronic opioid use while also avoiding systemic side effects. ​
Encouraging results from our Phase II Clinical Study of VPX638
Our plans to develop a new class of medications to reduce pain
What's new: Keep up with our progress